Why Cost Matters for Airsupra Adherence

You've prescribed Airsupra because it's the right clinical choice — a rescue inhaler that combines Albuterol and Budesonide to provide bronchodilation and anti-inflammatory protection simultaneously. But here's the reality: if your patient can't afford to fill it, the prescription is worthless.

Airsupra costs between $479 and $737 per inhaler without insurance. Even with coverage, many patients face high copays, prior authorization delays, or formulary exclusions that create barriers to access. Studies consistently show that cost is one of the top reasons patients don't fill or refill prescriptions — and for an expensive brand-only inhaler like Airsupra, the financial barrier is significant.

This guide is a practical toolkit for providers who want to help patients access Airsupra at a price they can manage.

What Your Patients Are Actually Paying

Before diving into solutions, it helps to understand the cost landscape:

• Cash price (no insurance): $479–$737 per inhaler (120 inhalations)
• Commercial insurance: Approximately 80% of commercially insured patients are in plans that cover Airsupra. Copays vary widely — some patients pay $30-$50, others face $150+ on specialty tiers.
• Medicare Part D: Coverage varies by plan. Many Part D formularies exclude Airsupra or place it on a high-cost tier.
• Medicaid: Coverage depends on the state program.
• Uninsured: Full cash price applies unless the patient qualifies for assistance programs.

The insurance landscape for Airsupra is evolving. Some plans require prior authorization, and others require step therapy (documenting that the patient tried Albuterol alone first). Your documentation of clinical necessity can make or break a prior authorization request.

Manufacturer Savings Programs

AstraZeneca offers several programs that can dramatically reduce patient costs:

SUPRA Savings Card

This is the most widely applicable program for commercially insured patients:

• Eligible patients may pay as little as $0 per inhaler
• Maximum savings of $130 per inhaler
• Available to patients with commercial insurance only (not valid for Medicare, Medicaid, VA, or other government programs)
• Patients can enroll at airsupra.com/savings-card or by calling 1-866-480-0030

Encourage your staff to mention this card at the point of prescribing. Many patients don't know manufacturer copay cards exist.

AZ&Me Prescription Savings Program

For patients who are uninsured or on Medicare Part D and cannot afford their medication:

• Income-based eligibility (tied to Federal Poverty Level guidelines)
• Can provide Airsupra at no cost or significantly reduced cost
• Patients apply at azandmeapp.com

This program is particularly valuable for your Medicare patients, who are ineligible for the SUPRA Savings Card.

AstraZeneca Direct

Launched in October 2025, this program offers:

• Airsupra for approximately $249 per inhaler (about 50% off list price)
• Home delivery directly to the patient
• Available at azpatientdirect.com

This is a good option for patients who don't qualify for the other programs but still find the full cash price prohibitive.

Coupon and Discount Cards

Beyond manufacturer programs, several third-party discount platforms can help reduce Airsupra costs:

• GoodRx — Shows pharmacy-specific pricing and discount coupons. Prices vary by location but can offer meaningful savings for cash-paying patients.
• SingleCare — Another coupon platform that negotiates pharmacy discounts. Worth checking alongside GoodRx since prices differ.
• RxSaver, Optum Perks, BuzzRx — Additional discount card platforms that may offer competitive pricing at certain pharmacies.

Keep in mind that coupon cards generally cannot be combined with insurance. They're most useful for uninsured patients or when the cash price with a coupon is lower than the patient's insurance copay.

Your patients can also compare prices across all these platforms at Medfinder, which aggregates pricing and availability information.

Generic Alternatives and Therapeutic Substitution

As of 2026, there is no generic Airsupra. However, if cost is a barrier and the patient cannot access savings programs, consider therapeutic alternatives:

Standard Albuterol Inhalers (ProAir, Ventolin, Proventil)

• Available as generics for significantly less
• Effective for acute bronchospasm
• Do not provide the anti-inflammatory benefit of Budesonide
• Best for patients with mild, infrequent symptoms

Symbicort or Breyna (Budesonide/Formoterol)

• ICS/LABA combination that can be used for MART (Maintenance and Reliever Therapy)
• Breyna is the generic alternative to Symbicort and is more affordable
• Not a direct substitute for Airsupra (different mechanism — LABA vs. SABA) but can serve as both maintenance and rescue in the right patient population

Levalbuterol (Xopenex)

• Purified Albuterol isomer with potentially fewer side effects
• No anti-inflammatory component
• May be covered by different formulary tiers than Airsupra

For a detailed comparison of alternatives, you can refer patients to our alternatives guide.

Building Cost Conversations Into Your Workflow

Many providers feel uncomfortable discussing cost. But for Airsupra — a medication that can cost more per month than some patients' car payments — the cost conversation is a clinical conversation.

At the Point of Prescribing

• Ask about insurance coverage: "Let's check if your plan covers Airsupra before I send this in."
• Mention savings proactively: "There's a manufacturer copay card that might bring your cost to $0 — let me get you that information."
• Set expectations: "This medication is expensive without help, so let's make sure we have a plan to keep it affordable."

Prior Authorization Tips

If a patient's insurance requires prior authorization for Airsupra:

• Document frequency of rescue inhaler use (high SABA use supports clinical need)
• Note any asthma exacerbations, ER visits, or hospitalizations
• Reference GINA guidelines supporting ICS-SABA combination as preferred rescue therapy
• Include evidence of step therapy failure if the plan requires trying Albuterol alone first

When the Patient Still Can't Afford It

Have a clear decision tree:

1. Try the SUPRA Savings Card (commercial insurance)
2. Apply for AZ&Me (uninsured or Medicare)
3. Check AstraZeneca Direct ($249 option)
4. Compare third-party coupon prices
5. If all else fails, discuss therapeutic alternatives and document why you're switching

Staff Training

Consider training your front office and clinical staff to:

• Hand patients the SUPRA Savings Card information at checkout
• Proactively check formulary coverage before submitting prescriptions
• Maintain a quick-reference sheet of assistance programs for high-cost medications

Helping Patients Find Airsupra in Stock

Cost isn't the only barrier — availability can be an issue too. Airsupra is not on the FDA shortage list, but as a newer brand-name product, many pharmacies don't routinely stock it. Let your patients know about Medfinder for Providers, which can help locate pharmacies with current stock.

For more details on the availability landscape, see our provider shortage update and our guide to helping patients find Airsupra in stock.

Final Thoughts

Airsupra is a clinically meaningful advance in rescue inhaler therapy. But clinical advances don't help patients who can't afford them. By building cost conversations and savings program awareness into your prescribing workflow, you can help ensure that the patients who need Airsupra can actually access it.

The programs exist. The savings are real. Your patients just need someone to point them in the right direction — and that someone is you.

Looking for more provider resources? Visit Medfinder for Providers for tools to help your patients find medications in stock and at affordable prices.